title: Chemobehavioural phenomics and behaviour-based psychiatric drug discovery in the zebrafish.
abstract: Despite their ubiquity and impact, psychiatric illnesses and other disorders of the central nervous system remain among the most poorly treated diseases. Most psychiatric medicines were discovered due to serendipitous observations of behavioural phenotypes in humans, rodents and other mammals. Extensive behaviour-based chemical screens would likely identify novel psychiatric drugs. However, large-scale chemical screens in mammals are inefficient and impractical. In contrast, zebrafish are very well suited for high-throughput behaviour-based drug discovery. Furthermore, the vast amounts of data generated from large-scale behavioural screens in zebrafish will facilitate a systems-level analysis of how chemicals affect behaviour. Unlike serendipitous discoveries in mammals, a comprehensive and integrative analysis of zebrafish chemobehavioural phenomics may identify functional relationships that would be missed by more reductionist approaches. Thus, behaviour-based chemical screens in the zebrafish may improve our understanding of neurobiology and accelerate the pace of psychiatric drug discovery.
authors.affiliation: Cardiovascular Research Center and Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, 149 13th Street, Charlestown, MA 02129, USA. dkokel@cvrc.mgh.harvard.edu
authors.forename: David
authors.initials: D
authors.lastname: Kokel
authors.forename: Randall T
authors.initials: RT
authors.lastname: Peterson
mesh_terms: D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology*; D001522:Behavior, Animal / Q000187:drug effects*; D055808:Drug Discovery; D015027:Zebrafish / Q000502:physiology*
chemical_list: D014150:Antipsychotic Agents
references.citation: Epilepsia. 2007 Jun;48(6):1151-7
references.pmid: 17521353
references.citation: Nature. 2006 May 25;441(7092):451-6
references.pmid: 16724057
references.citation: Nat Biotechnol. 2004 Oct;22(10):1253-9
references.pmid: 15470465
references.citation: Psychiatr Q. 2006 Spring;77(1):43-53
references.pmid: 16397754
references.citation: Ann Surg. 1918 Jul;68(1):5-11
references.pmid: 17863946
references.citation: Pharmacogenet Genomics. 2007 Apr;17(4):237-53
references.pmid: 17496723
references.citation: J Exp Biol. 1977 Feb;66(1):65-81
references.pmid: 870603
references.citation: Neuropsychopharmacology. 2008 Apr;33(5):1206-15
references.pmid: 17581529
references.citation: Prog Neurobiol. 2002 Oct;68(2):85-111
references.pmid: 12450489
references.citation: Epilepsy Res. 2007 Jun;75(1):18-28
references.pmid: 17485198
references.citation: Naunyn Schmiedebergs Arch Pharmacol. 2007 Apr;375(2):81-4
references.pmid: 17310263
references.citation: J Hist Behav Sci. 2006 Fall;42(4):379-98
references.pmid: 17024684
references.citation: PLoS Genet. 2005 Nov;1(5):e66
references.pmid: 16311625
references.citation: J Neurosci. 2006 Dec 20;26(51):13400-10
references.pmid: 17182791
references.citation: Nat Chem Biol. 2008 Jan;4(1):33-41
references.pmid: 18026094
references.citation: Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):12965-9
references.pmid: 11087852
references.citation: Nature. 2005 Sep 22;437(7058):491-3
references.pmid: 16177777
references.citation: Nat Rev Drug Discov. 2007 Jul;6(7):521-32
references.pmid: 17599084
references.citation: Neurotoxicol Teratol. 2007 Nov-Dec;29(6):652-64
references.pmid: 17761399
references.citation: J Neurosci. 2005 Oct 5;25(40):9294-303
references.pmid: 16207889
references.citation: Nat Genet. 2003 May;34(1):15-21
references.pmid: 12721547
references.citation: Nat Chem Biol. 2005 Dec;1(7):366-70
references.pmid: 16372403
references.citation: Am J Psychiatry. 1958 Nov;115(5):459-64
references.pmid: 13583250
references.citation: Clin Pharmacol Ther. 2007 Jul;82(1):70-80
references.pmid: 17495877
references.citation: Nat Biotechnol. 2004 May;22(5):595-9
references.pmid: 15097998
references.citation: Circulation. 2003 Mar 18;107(10):1355-8
references.pmid: 12642353
references.citation: Proc Am Thorac Soc. 2007 Jan;4(1):18-25
references.pmid: 17202287
references.citation: Brain Behav Evol. 2002;60(4):207-29
references.pmid: 12457080
references.citation: Epilepsy Res. 2006 Jan;68(1):22-8
references.pmid: 16377151
references.citation: J Dev Behav Pediatr. 2002 Feb;23(1 Suppl):S51-6
references.pmid: 11875291
references.citation: Nat Med. 2004 Jul;10 Suppl:S51-7
references.pmid: 15298008
references.citation: Chem Biol Drug Des. 2006 Oct;68(4):213-9
references.pmid: 17105485
references.citation: J Neurosci. 2007 May 2;27(18):4984-94
references.pmid: 17475807
references.citation: J Exp Biol. 2007 Jul;210(Pt 14):2526-39
references.pmid: 17601957
references.citation: J Affect Disord. 2008 May;108(1-2):1-9
references.pmid: 18001843
references.citation: Psychiatr Serv. 1999 Jul;50(7):969
references.pmid: 10402625
references.citation: Neuroscience. 2005;131(3):759-68
references.pmid: 15730879
references.citation: Nat Rev Drug Discov. 2004 Apr;3(4):353-9
references.pmid: 15060530
references.citation: Proc Natl Acad Sci U S A. 1995 Nov 7;92(23):10545-9
references.pmid: 7479837
references.citation: Methods Cell Biol. 2004;76:569-91
references.pmid: 15602893
references.citation: Brain Res. 2001 Jun 8;903(1-2):263-8
references.pmid: 11382414
references.citation: Trends Pharmacol Sci. 2007 Nov;28(11):588-96
references.pmid: 17963850
references.citation: Nat Protoc. 2006;1(5):2448-51
references.pmid: 17406490
references.citation: J Neurosci. 1999 Oct 1;19(19):8603-15
references.pmid: 10493760
references.citation: Nat Rev Neurosci. 2006 Feb;7(2):137-51
references.pmid: 16429123
references.citation: Neurotoxicol Teratol. 2006 Mar-Apr;28(2):245-50
references.pmid: 16527449
references.citation: Nat Neurosci. 2004 May;7(5):462-6
references.pmid: 15114359